Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit

NCT ID: NCT05710744

Last Updated: 2025-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

106 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-03-02

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a non randomized pilot trial aimed to:

Test the feasibility of an intervention to support intensive care unit clinicians in conducting shared decision making conversations with families of patients with acute respiratory failure. The goal of this intervention is to mitigate racial disparities in shared decision making.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The care of critically ill patients with acute respiratory failure involves life-or-death decisions. Ideally, intensive care unit (ICU) clinicians should include patients or their families in shared decision making, which promotes goal-concordant care (i.e., care aligned with patients' preferences), reduces psychological distress for both families and clinicians, and shortens ICU length of stay. However, racial disparities have been documented in shared decision making and associated outcomes. In outpatient settings, clinicians treat Black patients differently from White patients, providing fewer treatment options, less prognostic information, and less emotional support, and making assumptions about rather than eliciting patient preferences. Disparities in shared decision making are likely to be amplified in the ICU because clinicians often do not have long-standing relationships with patients or families, and decisions are complex, emotional, and time-pressured. Yet, no interventions currently exist to address racial disparities in shared decision making about acute respiratory failure. This research will directly fill this gap.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Care Disparities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Family Members of patients in the ICU

Family members will join routine meetings with the physicians treating with their critically ill loved ones.

Group Type NO_INTERVENTION

No interventions assigned to this group

ICU Physicians

Physicians will view a tip sheet containing information about best practices of shared decision making with diverse individuals. Physicians will then conduct routine meetings with families of patients with acute respiratory failure.

Group Type OTHER

Shared decision making tip sheet

Intervention Type BEHAVIORAL

Physicians will view tip sheets containing best practices for shared decision making with diverse families.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shared decision making tip sheet

Physicians will view tip sheets containing best practices for shared decision making with diverse families.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- ICU attending physician with at least 6 weeks of clinical service time in the 12 months preceding and following enrollment

Physician exclusion criterion:

\- Board certified in palliative care medicine


* Admitted to the ICU
* Being treated by a study physician currently and at least for the next 48 hours
* ≥ 18 years of age upon admission to hospital
* Mechanically ventilated ≥ 4 days

Patient exclusion criterion:

* Tracheostomy tube present or decision to pursue tracheostomy within next 7 days
* Has decision making capacity as assessed by medical team
* Extubation planned or death anticipated in next 24 hours
* Patients who are prisoners or are pregnant
* Awaiting organ transplantation during this hospitalization
* Acute respiratory failure due to progression of chronic neuromuscular disease
* No family decision maker available


* Identified by medical team as person most involved in medical decision making for the patient
* Confirmed to be patient's legally authorized representative
* Self-identifies as non-Hispanic, Black or White
* ≥ 18 years of age at time of consent
* Confirms conversational fluency in English
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Deepshikha Ashana, M.D.

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Brittany J McDowell, BSCR

Role: CONTACT

919-613-7321

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1K23HL164968-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00111530

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Uncertainty Management Intervention
NCT00938795 COMPLETED NA